Nebraska Cancer Institute — Omaha, Nebraska

Nebraska Cancer Institute is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Plasma Cell Disorder.

Sponsors: Heidelberg Pharma AG.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Institute?

Nebraska Cancer Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Institute conducted?

Nebraska Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Plasma Cell Disorder.

Is Nebraska Cancer Institute accredited by Crixeo Clinical Trials?

Nebraska Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.